Carl LeBel's Insider Trades & SAST Disclosures
Carl LeBel's most recent trade in Frequency Therapeutics Inc was a trade of 91,000 Restricted Stock Unit done . Disclosure was reported to the exchange on Jan. 26, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carl LeBel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 91,000 | 91,000 | - | - | Restricted Stock Unit | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 178,937 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 178,937 | 178,937 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 75,000 | 75,000 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 75,000 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 57,500 | 57,500 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 57,500 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 15,000 | 0 | - | - | Restricted Stock Unit | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 15,000 | 30,764 (0%) | 0% | - | Common Stock | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.52 per share. | 05 Jul 2022 | 4,421 | 26,343 (0%) | 0% | 1.5 | 6,720 | Common Stock |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.53 per share. | 18 Feb 2022 | 1,069 | 11,126 (0%) | 0% | 3.5 | 3,773 | Common Stock |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 18 Feb 2022 | 974 | 12,195 (0%) | 0% | 3.9 | 3,772 | Common Stock |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 150,000 | 150,000 | - | - | Restricted Stock Unit | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 4.19 per share. | 16 Feb 2022 | 901 | 13,169 (0%) | 0% | 4.2 | 3,774 | Common Stock |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 16 Feb 2022 | 831 | 14,070 (0%) | 0% | 4.4 | 3,680 | Common Stock |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 15,000 | 15,000 | - | - | Restricted Stock Unit | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 15,000 | 15,745 (0%) | 0% | - | Common Stock | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 4.33 per share. | 14 Feb 2022 | 844 | 14,901 (0%) | 0% | 4.3 | 3,655 | Common Stock |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2021 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Frequency Therapeutics Inc | Carl P. LeBel | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 75,000 | 75,000 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges